Ruthy A. R.
- Country
- Spain
- Department
- N/A
Research Overview
- Randomized Study of Cagrilintide + Semaglutide Combination vs Semaglutide Monotherapy for Weight Loss in Adults with Obesity (± Type 2 Diabetes)
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study of Brenipatide (LY3537031) for Efficacy and Safety in Adults with Irritable Bowel Syndrome‑Constipation
- Efficacy, Safety, and Pharmacokinetics of Single-Dose Albaconazole Versus Fluconazole and Placebo in Acute Vulvovaginal Candidiasis
Data & Insights
Has run more than one trial at 4 of 158 partner sites.
Specializations
Women's Health & Infections
The investigator specializes in the treatment of vulvovaginal candidiasis, focusing on developing therapeutic solutions for acute fungal infections affecting women's reproductive health.
- Fungal Infection Management
- Gynecological Conditions
- Antifungal Therapeutics
Their research encompasses innovative approaches in treating acute Candida infections with particular attention to single-dose treatment protocols.
Clinical Therapeutics
The investigator's work centers on evaluating novel antifungal medications, particularly in comparing the effectiveness of emerging therapeutic agents against established treatments.
- Treatment Efficacy Assessment
- Comparative Medicine
- Clinical Outcomes
Their expertise extends to investigating the clinical response and safety profiles of new therapeutic compounds in women's health.
Pharmacological Research
The investigator focuses on pharmacokinetic studies of antifungal medications, particularly examining single-dose therapeutic approaches for gynecological conditions.
- Drug Safety Evaluation
- Dose Optimization
- Treatment Innovation
Their research includes detailed analysis of medication efficacy and safety parameters in treating fungal infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.